TiMAX 3.5/4.0 mm Cannulated Screw System

Products	TiMAX 3.5/4.0 mm Cannulated Screw System
Company	DePuy Orthopaedics, Inc.
Item	TiMAX 3.5/4.0 mm Cannulated Screw System
Features	One convenient modular case Customizable selection AO quick connect instrumentation Self-drilling, self-tapping 4.0 mm screws New reduced head 4.0 mm screws TiMAX material offers greater head-torque strength than competition Uses 1.6 mm threaded guide wire for reliable positioning Unique thread design provides increased resistance to pull-out
Description	The 3.5/4.0 mm Cannulated Screw System is part of a series of modular systems developed by DePuy ACE for cannulated screws ranging from 3.5 to 8.0 mm. Matching a combination of screw options with necessary instrumentation, the system provides convenience and flexibility for the orthopaedic surgeon and the OR staff. The 3.5/4.0 mm system may be customized using two of three screw blocks that hold the following screw types: 3.5 mm cannulated cortical; 4.0 mm cannulated cancellous with a standard head; and 4.0 mm cannulated cancellous (full thread or lag) with a reduced head. Consistent with all DePuy ACE implants, the screws offer the TiMAXTM benefits of increased strength, superior biocompatibility and enhanced imaging capabilities.
Info	DePuy Orthopaedics, Inc. Customer Service: (800) 366-8143 Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

TAG: TiMAX Cannulated Screw System

...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...

Medicine Products:

Allergen, Food, Cherry Allergen, Food, Chicken Allergen, Food, Casein Allergen, Food, Blueberry

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...sity in Caracas found that Lactobacillus casei (L ...d its flatulence capacity// and increased the nutr... nutrition especially in the developing countries....eam to analyze the method of creating flatulence-f...

...come into force in September 2006, will allow pati... to receive organs// from living donors who are un...allowed between people who are genetically or emot...nced by the by the Human Tissue Authority, which w...

...ify that the complete cancer has been removed at b...shed in the May issue of Radiology.// Researchers ... electromagnetic spectrum--the terahertz region--t...rmine if the removed tissue margins were clear of ...

...rsity researchers suggests that injuries related t...e emergency department//. Wearing of protective ey...isk of eye injury can avoid such instances. The r...d 2003, some 27,000 people went to the emergency d...

Other Medicine News:Health News:New Hope For Patients Needing Kidney Transplants In UK 2 Health News:Terahertz Imaging Promises To Revolutionize Breast Cancer Treatments 2 Health News:Watch Out! Eye Glass Related Injuries On The Rise 2 Health News:Watch Out! Eye Glass Related Injuries On The Rise 3

Beans Devoid Of Flatulence Causing Compounds Would Soon Hit The Market New Hope For Patients Needing Kidney Transplants In UK Terahertz Imaging Promises To Revolutionize Breast Cancer Treatments Watch Out! Eye Glass Related Injuries On The Rise

(Date:8/17/2008)...- Pharmaxis,(ASX: PXS; Nasd...hase 3,clinical trial of Bronchitol for the treatm...The first efficacy data from the trial is expected...e trial commenced its dosing phase in,April 2007, ...ects in June,2008 and closed today with 325 subjec...

(Date:8/14/2008)... showing clinical benefit in cancer,patients; Blin... and attack cancer ce.../ -- Micromet, Inc.,(Nasdaq: MITI ), a biopharmac...bodies for the treatment of cancer, inflammation a...n of a Phase 1 clinical study(1) on its,BiTE(R) an...

(Date:8/13/2008)...all/ -- As biotechnology,pharmaceutical and medic...als beyond their own borders to other parts of the...rica, complicated regulatory environments,challeng...o an analysis by,Aon Corporation (NYSE: AOC ). Ao...ompanies a visual representation of the complex in...

(Date:8/13/2008).../ -- Today positron emission,tomography (PET) scan...gy,tool for diagnosis, staging and monitoring. It ...logy emitting a radioactive tracer to localize,tum...normal tissue. As a,result, the malignant tissue s... spot.", The use of multiple imaging technologies...

Breaking Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6 Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2 Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3 Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4 Are PET Scans Beneficial During Cancer Diagnosis, Staging and Monitoring? 2 Seeking sustainability in a world of instability 2198 1 Seeking sustainability in a world of instability 2198 2 Duragesic Trials Continue Plaintiffs Optimistic After Latest Recall 11870 1 Duragesic Trials Continue Plaintiffs Optimistic After Latest Recall 11870 2 Cancer Drug Works Against MS in Early Trial 11869 1 Cancer Drug Works Against MS in Early Trial 11869 2 Cancer Drug Works Against MS in Early Trial 11869 3 Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results 3275 1

[1] Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment [0] Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab [0] Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders [0] Are PET Scans Beneficial During Cancer Diagnosis, Staging and Monitoring?

...wire-FirstCall/ -- Vical,Incorporated today announ...ith the company,s Vaxfectin(TM) adjuvant generated...nformulated vaccine,at the same dose in a recently...steur,s Fluzone(R) commercial vaccine with,Vaxfect...vaccine,dose while generating equivalent or better...

...Apr 10, 2007 - Valeant,Pharmaceuticals Internation...hase 2 data for retigabine, a first-in-class,neuro...ing,independent, scientific journal. The authors c...monstrated reduction in monthly,seizure rates in t...d RESTORE2) are currently underway to further inve...

Other Medicine Technology:Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 2 Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 3 Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 4 Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine 5 Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 2 Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 3

Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With,Seasonal Influenza Vaccine Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology